Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Drug Metabolism and Pharmacokinetics|September 13, 2024
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and FlucloxacillinHeshu Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 25, 2007
On verification of hyperthermia treatment planning for cervical carcinoma patientsP M A van Haaren, H P Kok, C A T van den Berg, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 20, 1998
ESHO quality assurance guidelines for regional hyperthermiaJ J Lagendijk, G C Van Rhoon, S N Hornsleth, et al.
Pharmaceutics|January 21, 2023
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised PatientsDaan W Huntjens, Jacob A Dijkstra, Lisanne N Verwiel, et al.
British Journal of Haematology|August 11, 2023
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioningMesire Aydin, David C de Leeuw, Caroline E Rutten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2022
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-studyHenrike Westerveld, Kathrin Kirchheiner, Remi A Nout, et al.
The Lancet. Oncology|October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines CommitteeJaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Leukemia|January 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemiaJesse M Tettero, Maaike E Heidinga, Tim R Mocking, et al.
European Journal of Haematology|December 27, 2024
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromeMan Wai Tang, Deborah Van der Tuin, Mesire Aydin, et al.
Clinical Pharmacology and Therapeutics|June 23, 2025
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose RecommendationsRashudy F Mahomedradja, Tim Bognàr, Kaj E van Schie, et al.
Pageof 10